legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

## Exscientia to Report Financial Results for Q1 2024

Exscientia plc (Nasdaq: EXAI) will be releasing its financial results for the first quarter ended March 31, 2024, on Tuesday, May 21, 2024. The announcement will take place before the opening of U.S. markets. Investors and interested parties are invited to join a conference call and webcast scheduled for 1:30 p.m. BST / 8:30 a.m. EDT on the same day.

### How AI legalese decoder Can Help

AI legalese decoder can assist stakeholders in analyzing and understanding the financial details and implications of Exscientia’s Q1 2024 results. By leveraging AI technology, the platform can decode complex legal and financial language, making it easier for users to interpret and act upon the information provided in the company’s report.

The live webcast of the call can be accessed through the “Investors and Media” section of the Exscientia website at investors.exscientia.ai. Alternatively, participants can join the conference call by dialing the following numbers: +1 (888) 330 3292 (U.S.), +44 (800) 358 0970 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895. A replay of the call will be available for 90 days in the “Events and Presentations” section of the Exscientia website.

### About Exscientia

Exscientia is a leading AI-driven precision medicine company focused on discovering, designing, and developing innovative drugs efficiently. The company’s groundbreaking precision oncology platform has proven successful in guiding treatment selection and improving patient outcomes. Additionally, Exscientia has made significant advancements in progressing AI-designed small molecules into clinical trials. The company’s internal pipeline is concentrated on leveraging precision medicine in oncology, while its partnered pipeline extends to other therapeutic areas. By revolutionizing medicine creation, Exscientia aims to transform scientific breakthroughs into effective medicines for patients.

To learn more about Exscientia, visit www.exscientia.ai or follow the company on LinkedIn @ex-scientia and Twitter @exscientiaAI.

### Contact Information

#### Investor Relations Contact:
– Sara Sherman / Chinedu Okeke
– Email: [email protected]

#### Media Contact:
– Oliver Stohlmann
– Email: [email protected]

By utilizing AI legalese decoder, investors and analysts can gain deeper insights into Exscientia’s financial results, enabling them to make informed decisions based on decoded legal and financial information.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link